✦ Verified product
SS-31
USD 29.99
Strength
Newtide
Verified independent store
→
Mitochondria-targeted tetrapeptide (Forzinity). FDA-approved September 2025 for Barth syndrome—first FDA-approved mitochondria-targeted therapeutic.
